United States

People: Achaogen Inc (AKAO.OQ)

AKAO.OQ on NASDAQ Stock Exchange Global Market

22 Mar 2019
Change (% chg)

$-0.04 (-6.39%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Roberts, Bryan 

Dr. Bryan E. Roberts, Ph.D., is Independent Chairman of the Board of the Company. Dr. Roberts joined Venrock, a venture capital investment firm, in 1997, where he currently serves as Partner. From 1989 to 1992, Dr. Roberts worked in the corporate finance department of Kidder, Peabody & Co., a brokerage company. Dr. Roberts also currently serves as the chairman of the board of Castlight as well as a chairman and director of several private companies. Dr. Roberts previously served on the board of directors of publicly traded Athenahealth, Inc. from 1999 to 2009, XenoPort, Inc., from 2000 to 2007, Sirna Therapeutics, Inc. from 2003 to 2007, Vitae Pharmaceuticals, Inc. from 2001 to 2016, Zeltiq Aethetics, Inc. from 2008 to 2016 and Ironwood Pharmaceuticals, Inc. from 2001 to 2016. Dr. Roberts holds a B.A. in Chemistry from Dartmouth College and a Ph.D. in Chemistry and Chemical Biology from Harvard University.

Basic Compensation

Total Annual Compensation, USD 206,809
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 206,809

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --